1. Home
  2. PHR vs TXG Comparison

PHR vs TXG Comparison

Compare PHR & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHR
  • TXG
  • Stock Information
  • Founded
  • PHR 2005
  • TXG 2012
  • Country
  • PHR United States
  • TXG United States
  • Employees
  • PHR N/A
  • TXG N/A
  • Industry
  • PHR Business Services
  • TXG Biotechnology: Laboratory Analytical Instruments
  • Sector
  • PHR Consumer Discretionary
  • TXG Industrials
  • Exchange
  • PHR Nasdaq
  • TXG Nasdaq
  • Market Cap
  • PHR 1.5B
  • TXG 1.2B
  • IPO Year
  • PHR 2019
  • TXG 2019
  • Fundamental
  • Price
  • PHR $26.23
  • TXG $10.81
  • Analyst Decision
  • PHR Strong Buy
  • TXG Buy
  • Analyst Count
  • PHR 12
  • TXG 15
  • Target Price
  • PHR $31.50
  • TXG $15.81
  • AVG Volume (30 Days)
  • PHR 614.2K
  • TXG 3.7M
  • Earning Date
  • PHR 05-28-2025
  • TXG 08-07-2025
  • Dividend Yield
  • PHR N/A
  • TXG N/A
  • EPS Growth
  • PHR N/A
  • TXG N/A
  • EPS
  • PHR N/A
  • TXG N/A
  • Revenue
  • PHR $434,532,000.00
  • TXG $624,662,000.00
  • Revenue This Year
  • PHR $14.74
  • TXG N/A
  • Revenue Next Year
  • PHR $11.57
  • TXG $5.70
  • P/E Ratio
  • PHR N/A
  • TXG N/A
  • Revenue Growth
  • PHR 16.29
  • TXG N/A
  • 52 Week Low
  • PHR $17.07
  • TXG $6.78
  • 52 Week High
  • PHR $30.53
  • TXG $24.76
  • Technical
  • Relative Strength Index (RSI)
  • PHR 53.10
  • TXG 62.32
  • Support Level
  • PHR $24.80
  • TXG $10.38
  • Resistance Level
  • PHR $28.40
  • TXG $11.10
  • Average True Range (ATR)
  • PHR 0.96
  • TXG 0.57
  • MACD
  • PHR -0.06
  • TXG 0.10
  • Stochastic Oscillator
  • PHR 52.15
  • TXG 83.45

About PHR Phreesia Inc.

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: